Arcum TherapeuticsTM Consulting Services
We’re here to support the fight against Antimicrobial Resistance
The World Bank, WHO, CDC have all published concerns that Antimicrobial Resistance (AMR) is a large and growing global health issue. Some estimate that AMR could cost an additional $1 Trillion to the global healthcare system by 2050. The lack of novel antimicrobial agents being developed and commercialized is adding to the healthcare need.
We are all in this together-that’s why we provide expert consulting services for antimicrobial development and commercialization.
